Tarek Abou Zeid

Circulating CXCL13 could be served as a biomarker for chronic lymphocytic leukemia severity.

S. Aref, Ahmed M Ramez, Doaa Atia, 2021, Cancer biomarkers : section A of Disease markers.

Clinicopathologic Effect of DNMT3A Mutation in Adult T-Cell Acute Lymphoblastic Leukemia.

S. Aref, M. El-Baiomy, Nadia El Menshawy, 2016, Clinical lymphoma, myeloma & leukemia.

Prevalence and Clinical Effect of IDH1 and IDH2 Mutations Among Cytogenetically Normal Acute Myeloid Leukemia Patients.

S. Aref, M. El-Baiomy, M. El-Ghonemy, 2015, Clinical lymphoma, myeloma & leukemia.